Rare Disease compound family | Anubis Research

Compound Family

Rare Disease dossiers

Orphan drug therapeutics addressing genetic and ultra-rare conditions with precision mechanisms.

Showing 10 of 10 compounds

Hold to activate 3D

Molecular

View 3D Structure

Rare Disease

Amondys 45

Pharmaceutical medication (Casimersen)

TherapeuticClinical Research

Hold to activate 3D

Molecular

View 3D Structure

Rare Disease

Cablivi

Pharmaceutical medication (Caplacizumab-yhdp)

TherapeuticClinical Research

Hold to activate 3D

Molecular

View 3D Structure

Rare Disease

Empaveli

Pharmaceutical medication (Pegcetacoplan)

TherapeuticClinical Research

Hold to activate 3D

Molecular

View 3D Structure

Rare Disease

Evrysdi

Pharmaceutical medication (Risdiplam)

TherapeuticClinical Research

Hold to activate 3D

Molecular

View 3D Structure

Rare Disease

Exondys 51

Pharmaceutical medication (Eteplirsen)

TherapeuticClinical Research

Hold to activate 3D

Molecular

View 3D Structure

Rare Disease

Spinraza

Pharmaceutical medication (Nusinersen Sodium)

TherapeuticClinical Research

Hold to activate 3D

Molecular

View 3D Structure

Rare Disease

Tavneos

Pharmaceutical medication (Avacopan)

TherapeuticClinical Research

Hold to activate 3D

Molecular

View 3D Structure

Rare Disease

Ultomiris

Pharmaceutical medication (Ravulizumab-cwvz)

TherapeuticClinical Research

Hold to activate 3D

Molecular

View 3D Structure

Rare Disease

Viltepso

Pharmaceutical medication (Viltolarsen)

TherapeuticClinical Research

Hold to activate 3D

Molecular

View 3D Structure

Rare Disease

Vyondys 53

Pharmaceutical medication (Golodirsen)

TherapeuticClinical Research

Enable JavaScript to finish loading this pageTurn on JavaScript in your browser and reload. For ordering help, email support@anubis.estate.

Loading your page…